Pulse Biosciences Inc

Pulse Biosciences, Inc. is a bioelectric medicine company. It offers the nPulse System, a Nanosecond Pulsed-Field Ablation delivery platform for treating benign skin lesions. Other products include the nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical settings, the nPulse Cardiac Surgical Clamp for surgical treatment of atrial fibrillation (AF), the nPulse Cardiac Catheter System for circumferential ablation in a single treatment cycle, and the nPulse Console, a software-enabled console-based platform designed to accommodate physicians' preferred clinical workflow. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. It was incorporated in 2014 and is headquartered in Miami, Florida.